Rafael Holdings, Inc. RFL Product Revenue — Cost Of Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Rafael Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The official record: Rafael Holdings, Inc.’s 10-Q, filed June 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rafael Holdings, Inc.'s product revenue — cost of revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rafael Holdings, Inc.'s product revenue — cost of revenue?
- Rafael Holdings, Inc. (RFL) reported product revenue — cost of revenue of $8K in Q1 2026.
- How has Rafael Holdings, Inc.'s product revenue — cost of revenue changed year-over-year?
- Rafael Holdings, Inc.'s product revenue — cost of revenue decreased by 11.1% year-over-year, from $9K to $8K.
- What does product revenue — cost of revenue mean?
- This metric captures the direct costs incurred to produce and deliver the pharmaceutical products sold within the specified business segment. It includes expenses such as raw materials, manufacturing overhead, and direct labor associated with the commercialization of therapies. Monitoring this cost provides insight into the production efficiency and gross margin profile of the company's product-based operations.